Literature DB >> 20954793

Ocular acid burn due to 20% concentrated salicylic acid.

Tarek A Shazly1.   

Abstract

This is a case report of severe conjunctival and corneal epithelial defects resulting from accidental exposure to salicylic acid that was mistakenly used instead of artificial tears (eye drops). The patient was treated with tobramycin 0.3%-dexamethasone 1% 3 times a day, cyclopentolate 1% twice a day, and artificial tears 6 times a day and underwent daily examinations until the corneal and conjunctival epithelial defects resolved. The corneal and conjunctival epithelial defects slowly resolved over 14 days. Visual acuity improved to its preinjury level of 20/40 in the affected eye. No residual corneal scarring was evident. Slowly resolving corneal and conjunctival epithelial defects can occur from direct contact with salicylic acid; therefore, this medication should be packaged and labeled differently from eye drops.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954793     DOI: 10.3109/15569527.2010.521536

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  4 in total

1.  Chemical burn to the eyes.

Authors:  Justin Klaff; Stephen M Milner; Stuart Farris; Leigh Ann Price
Journal:  Eplasty       Date:  2011-11-17

2.  A case of the blues: Inadvertent ocular injury from accidental instillation of blue ink.

Authors:  Alexander D Port; Ashley R Brissette; Kimberly C Sippel
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-10

3.  Severe corneal burn due to the accidental application of salicylic acid packed in a plastic dropper bottle.

Authors:  Virgilio Galvis; Alejandro Tello; Néstor I Carreño; Camilo A Niño; Natalia A García; Valeria Otoya; Rodrigo Arana
Journal:  Biomedica       Date:  2020-09-01       Impact factor: 0.935

4.  Ocular chemical burns from accidental exposure to topical dermatological medicinal agent.

Authors:  Jitender Jinagal; Parul C Gupta; Gaurav Gupta; Kamal K Sahu; Jagat Ram
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.